Shares of Cronos Group Inc. (NASDAQ:CRON - Get Free Report) saw an uptick in trading volume on Tuesday . 1,699,193 shares changed hands during trading, a decline of 1% from the previous session's volume of 1,708,781 shares.The stock last traded at $2.50 and had previously closed at $2.67.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen lowered shares of Cronos Group from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th.
Check Out Our Latest Stock Analysis on Cronos Group
Cronos Group Stock Performance
The stock has a market capitalization of $907.80 million, a P/E ratio of 47.40 and a beta of 1.01. The firm's fifty day simple moving average is $2.06 and its 200 day simple moving average is $1.96.
Cronos Group (NASDAQ:CRON - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.08). Cronos Group had a net margin of 14.19% and a negative return on equity of 3.78%. The company had revenue of $33.46 million during the quarter, compared to analyst estimates of $45.73 million. Analysts anticipate that Cronos Group Inc. will post -0.03 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Cronos Group
Several hedge funds have recently added to or reduced their stakes in CRON. Tower Research Capital LLC TRC raised its holdings in Cronos Group by 140.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock worth $28,000 after purchasing an additional 8,019 shares during the last quarter. International Assets Investment Management LLC bought a new position in Cronos Group during the 2nd quarter worth approximately $33,000. Aigen Investment Management LP bought a new position in Cronos Group during the 1st quarter worth approximately $35,000. Chicago Partners Investment Group LLC bought a new position in Cronos Group during the 2nd quarter worth approximately $36,000. Finally, Envestnet Asset Management Inc. bought a new position in Cronos Group during the 2nd quarter worth approximately $36,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.
About Cronos Group
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Stories
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.